These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3516877)

  • 1. Lack of biological significance of in vitro Brugia malayi microfilarial cytotoxicity mediated by Propionibacterium acnes ("Corynebacterium parvum")-and Mycobacterium bovis BCG-activated macrophages.
    Fanning MM; Kazura JW
    Infect Immun; 1986 May; 52(2):534-7. PubMed ID: 3516877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro killing of schistosomula of Schistosoma mansoni by BCG and C. parvum-activated macrophages.
    Mahmoud AA; Peters PA; Civil RH; Remington JS
    J Immunol; 1979 May; 122(5):1655-7. PubMed ID: 376723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoregulation of antitumor response; differential secretion of arachidonic acid metabolites by macrophages during stimulation in vitro with BCG and Corynebacterium parvum.
    Tomecki J; Sukiennik J; Kordowiak A
    Arch Immunol Ther Exp (Warsz); 1993; 41(1):45-50. PubMed ID: 8239907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host defenses in murine malaria: nonspecific resistance to Plasmodium berghei generated in response to Mycobacterium bovis infection or Corynebacterium parvum stimulation.
    Murphy JR
    Infect Immun; 1981 Jul; 33(1):199-211. PubMed ID: 7021424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of I-A expression by murine peritoneal macrophages: differences linked to the Bcg gene.
    Zwilling BS; Vespa L; Massie M
    J Immunol; 1987 Mar; 138(5):1372-6. PubMed ID: 3543128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canine migration inhibitory factor: effect of Corynebacterium parvum administration.
    Pineiro MS; Bowles CA; Cutchins EC; Bull MI
    Infect Immun; 1977 Oct; 18(1):102-9. PubMed ID: 332636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Corynebacterium parvum in the activation of peritoneal macrophages. 1. Association between intracellular C. parvum and cytotoxic macrophages.
    Chapes SK; Haskill S
    Cell Immunol; 1982 Jun; 70(1):65-75. PubMed ID: 7116464
    [No Abstract]   [Full Text] [Related]  

  • 8. Fate of Legionella pneumophila Philadelphia-1 strain in resident, elicited, activated, and immune peritoneal macrophages of guinea pigs.
    Yoshida S; Mizuguchi Y; Nikaido Y; Mitsuyama M; Nomoto K
    Infect Immun; 1987 Oct; 55(10):2477-82. PubMed ID: 3308708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCG, Corynebacterium parvum or Mycobacterium leprae added to cultures of BCG-primed mouse spleen cells cause an enhanced primary antibody response in vitro.
    Brown CA; Brown IN; Sljivić VS
    Immunology; 1981 Jan; 42(1):67-73. PubMed ID: 7007221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulation of host resistance to experimental viral infections in mice: effects of Corynebacterium acnes, Corynebacterium parvum, and Bacille calmette-guérin.
    Glasgow LA; Fischbach J; Bryant SM; Kern ER
    J Infect Dis; 1977 May; 135(5):763-70. PubMed ID: 192811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon production by Corynebacterium parvum and BCG-activated murine spleen macrophages.
    Neumann C; Macher E; Sorg C
    Immunobiology; 1980 Apr; 157(1):12-23. PubMed ID: 6162779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective tumoricidal capacity of macrophages from A/J mice. I. Characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
    Boraschi D; Meltzer MS
    J Immunol; 1979 Apr; 122(4):1587-91. PubMed ID: 376720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variations in complement activation of Brugia patei, B. malayi and B. pahangi microfilariae.
    Rao UR; Vickery AC; Nayar JK; Kwa BH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Apr; 7(4):160-7. PubMed ID: 2030522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of the non-specific resistance by Corynebacterium parvum and Bacillus calmette Guérin.
    Ruitenberg EJ; Steerenberg PA
    Tijdschr Diergeneeskd; 1976 Jul; 101(14):775-8. PubMed ID: 821172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental cancer immunotherapy: comparison of tumor rejection if F344 rats given live Mycobacterium bovis (Strain BCG) and killed Corynebacterium parvum.
    Likhite VV
    J Natl Cancer Inst; 1976 May; 56(5):985-9. PubMed ID: 994209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophages in resistance to rickettsial infections: protection against lethal Rickettsia tsutsugamushi infections by treatment of mice with macrophage-activating agents.
    Nacy CA; Meltzer MS
    J Leukoc Biol; 1984 Apr; 35(4):385-96. PubMed ID: 6584528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of anti-thymocyte serum, anti-macrophage serum, and latex particles on the therapeutic efficacy of BCG or Corynebacterium liquefaciens (Propionibacterium acnes C7) in syngeneic mice.
    Tanaka T; Nakagawa H; Kato A; Yoshimura M; Fujita H; Kimura K
    Gan; 1977 Feb; 68(1):45-52. PubMed ID: 324858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective tumoricidal capacity of macrophages from P/J mice: characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
    Boraschi D; Meltzer MS
    J Immunol; 1980 Aug; 125(2):771-6. PubMed ID: 6993562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of resistance to ectromelia virus infection by corynebacterium parvum in murine peritoneal macrophages.
    Cohen DA; Bubel HC
    J Reticuloendothel Soc; 1983 Jan; 33(1):35-46. PubMed ID: 6300395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage functions in Biozzi mice.
    Dockrell HM; Taverne J; Lelchuk R; Depledge P; Brown IN; Playfair JH
    Immunology; 1985 Jul; 55(3):501-9. PubMed ID: 3894222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.